Clinical Trial: Study on the mechanism of SPH3127 regulating vascular endothelial cell energy metabolism reprogramming under HTN driven by FXYD1 (China)

China, Nov. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the mechanism of SPH3127 regulating vascular endothelial cell energy metabolism reprogramming under HTN driven by FXYD1'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135570

Registration Time: 2026/10/30

Type: Observational study

Primary Sponsor: The First Affiliated Hospital of the Baotou Medical College of Inner Mongolia University of Science and Technology

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=348754

Published by HT Digital Content Services with permission from Health Daily Digest....